IGI receives CIRM Inception Award to study mechanisms in blood cancers

The IGI has been awarded a CIRM Inception Award to use gene editing in bone marrow stem cells in order to discover mechanisms that lead to certain types of blood cancers.  The CIRM Inception Awards provide seed funding to support the exploration of transformational ideas that hold the potential to greatly impact the field of human stem cell research.  The IGI will use genetic engineering to determine how mutations frequently observed in the bone marrow stem cells of patients lead to a family of diseases called meyloproliferative neoplasms (MPNs).  The MPN disorders are characterized by over-production of certain blood cells, such as red blood cells or platelets, but it is unclear how patient mutations cause these disorders.  A better understanding of how MPN-associated mutations lead to disease could eventually lead to better therapies for patients suffering from MPN.

SUBMIT A COMMENT

Your email address will not be published.

Filters

Latest News

November 1, 2022

Welcome to David

David received his PhD in Biochemistry from the University of Cambridge in 2022 under the supervision of Prof. Steve Jackson. His work focused on identifying...

October 4, 2022

Welcome to Jan

Jan received his Master´s degree in Immunology from Charles University in 2022, working with Dr. Petr Kašpárek on the role of TNFR1 signalling in the Netherton...

October 4, 2022

Welcome to Ana

Ana received her PhD in Cancer Biology at the University of Zurich, Switzerland. She carried out her pre-and postdoctoral research studies at the Balgrist...

News Archive

Tweets